Tularemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2017-06-02
EMA Application withdrawn: Solithromycin Triskel EU Services (solithromycin) — Triskel EU Services Ltd
The EMA reports withdrawal of the Solithromycin application by Triskel EU Services Ltd for uses including tularemia, pneumonia, and anthrax.